Connection
Jeffrey Olson to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Jeffrey Olson has written about Clinical Trials, Phase II as Topic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.021 |
|
|
|
-
Dixon JA, Oliver SC, Olson JL, Mandava N. VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration. Expert Opin Investig Drugs. 2009 Oct; 18(10):1573-80.
Score: 0.021